DuPont CEO gives investors confidence Dow deal is on track
Company says Q1 income will decline about 18% from a year earlier, partly because of a merger-related expense
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Houston
DUPONT Co said it can address antitrust regulators' concerns that its merger with Dow Chemical Co could limit discovery of new agricultural pesticides, boosting investor confidence that the US$72 billion deal will be approved.
Regulators are mostly concerned that the combination could hurt innovation in crop-protection chemicals, chief executive officer Ed Breen said on Tuesday on a conference call to discuss fourth-quarter results.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
